$HUM (Humana Inc.)

$HUM {{ '2016-02-19T09:59:04+0000' | timeago}} • Announcement

Health and well-being company $HUM said its BoD has declared a dividend of $0.29 per share payable on April 29, 2016 to stockholders of record on March 31, 2016.

$HUM {{ '2017-08-28T20:58:21+0000' | timeago}} • Announcement

$HUM completed $1.50Bil accelerated share repurchase program, repurchasing a total of about 6.67MM shares at an average price of $224.81 per share. This was completed as part of its current $2.25Bil share repurchase authorization expiring on Dec. 31, 2017. As of Aug. 28, 2017, about $750MM of the total $2.25Bil authorization was remaining.

$HUM {{ '2017-08-21T21:07:50+0000' | timeago}} • Announcement

$HUM, an insurance company, has elected Frank Bisignano as a member of its BoD. Bisignano is Chairman of the Board and CEO of First Data. His election brings the number of Humana Directors to 11.

$HUM {{ '2017-08-18T15:28:02+0000' | timeago}} • Announcement

$HUM's BoD declared a cash dividend of $0.40 per share payable to stockholders on October 27, 2017 of record on September 29, 2017.

$HUM {{ '2017-08-15T19:10:28+0000' | timeago}} • Announcement

$HUM signed a new contract with Summit Health that provides in-network access for Humana Medicare members at Summit Health facilities and providers in south-central Pennsylvania. The contract is effective Aug. 1, 2017. Terms of the agreement were not disclosed.

$HUM {{ '2017-08-02T14:49:30+0000' | timeago}} • Webcast

$HUM stated that it is optimistic about growth in the Medicare Advantage business for FY18. The company has tried to maintain stability in benefits and also improve relationships with brokers. $HUM believes its Net Promoter Score combined with other factors will help in retention which is a positive for the business.

$HUM {{ '2017-08-02T14:34:35+0000' | timeago}} • Webcast

During 2Q17, $HUM’s total premiums and services revenues dropped 3% to $13.43Bil from 2Q16. The YoY decrease primarily reflects lower Individual Commercial segment revenues, partially offset by higher Retail segment revenues primarily resulting from the company’s Medicare business. The consolidated benefit ratio was 82.5% in 2Q17.

$HUM {{ '2017-08-02T13:11:00+0000' | timeago}} • Infographic

$HUM Humana Inc Earnings AlphaGraphic: Q2 2017 Highlights

$HUM {{ '2017-08-02T12:21:09+0000' | timeago}} • Announcement

$HUM raised its GAAP and adjusted EPS guidance for FY17. FY17 GAAP EPS was increased to approx. $17.83 from the previous guidance of at least $16.91, while adjusted EPS was increased to approx. $11.50 from the previous guidance of at least $11.10. The guidance increases were primarily driven by strong results in the Retail segment.

$HUM {{ '2017-08-02T12:17:06+0000' | timeago}} • Announcement

$HUM reported net income of $650MM or $4.46 per share in 2Q17 compared to $311MM or $2.06 per share in 2Q16. Consolidated revenues for 2Q17 were $13.53Bil, a decrease of 3% from $14.01Bil in 2Q16.

$HUM {{ '2017-07-12T13:21:50+0000' | timeago}} • Announcement

$HUM and Oscar Health are launching a strategic partnership to offer commercial health insurance to small businesses in a nine-county Nashville, Tenn. area.

$HUM {{ '2017-06-23T14:50:33+0000' | timeago}} • Announcement

$HUM has named Sam Deshpande to the newly created position of SVP and Chief Risk Officer. Mr. Deshpande will report directly to President and CEO Bruce Broussard. He comes to $HUM from Capital One.

$HUM {{ '2017-05-03T14:48:46+0000' | timeago}} • Webcast

$HUM said that it is selectively looking at group Medicare Advantage plan opportunities. The company has a team working on this and is confident on making adequate return on capital. There is no additional investment for group MA product in 2017. Humana depends on the competitive landscape and its relative market position.

$HUM {{ '2017-05-03T13:49:15+0000' | timeago}} • Announcement

As Humana posted 1Q17 results, $HUM reaffirmed its recent guidance for FY17 EPS guidance of at least $16.91. Total revenues are seen at $53.5-54.5Bil, with a capex of $550-600MM and cash flows from operations of $2.8-3.2Bil for the year.

$HUM {{ '2017-05-03T13:43:27+0000' | timeago}} • Announcement

Net revenue at $HUM slipped 0.3% to $13.8Bil in 1Q17, as its net income jumped more than four times to $1.1Bil from last year's $254MM. Earnings rose to $7.49 per diluted share from $1.68 a share, as Humana saw $947MM in merger termination gains for the quarter.

$AET {{ '2017-05-02T10:25:16+0000' | timeago}} • Announcement

$AET slipped to a loss in 1Q17 from a profit last year, due to costs associated with the termination of $HUM merger agreement. Net loss was $381MM or $1.11 per share compared to a profit of $737MM or $2.08 per share last year. Revenue declined 3% to $15.17Bil. Adjusted EPS increased to $2.71 from $2.32.

$HUM {{ '2017-04-20T13:17:09+0000' | timeago}} • Announcement

$HUM's BoD declared a quarterly cash dividend of $0.40 per share. The dividend is payable on July 31, 2017 to stockholders of record as of June 30, 2017.

$HUM {{ '2017-04-18T11:51:55+0000' | timeago}} • Announcement

$HUM realigned certain of its businesses for its financial reporting segments to correspond with internal management reporting changes and its planned exit from the individual commercial medical business on Jan. 1, 2018. The company’s segments now include Retail, Group and Specialty, Healthcare Services, and Individual Commercial.

$HUM {{ '2017-03-17T10:53:21+0000' | timeago}} • Announcement

$HUM completed its public offering of $1.0Bil in senior notes. These senior notes are comprised of $600MM 3.95% notes and $400MM 4.8% notes. Humana expects the net proceeds of approximately $988MM after expenses, to be used for general corporate purposes.

$HUM {{ '2017-02-14T15:19:12+0000' | timeago}} • Announcement

$HUM announced the mutual termination of the merger agreement with $AET. Under the terms of the merger agreement, $HUM is entitled to a breakup fee of $1Bil, or approx $630MM, net of tax.

$HUM {{ '2017-02-08T12:15:40+0000' | timeago}} • Announcement

$HUM said James Murray, EVP and COO, has decided to retire from that position effective March 31, 2017, and has agreed to serve as an advisor to the company through the end of the year. At this time, $HUM does not anticipate filling the COO role.

Recent Transcripts

IMUC (ImmunoCellular Therapeutics, Ltd.)
Wednesday, August 23 2017 - 9:00pm
ONVO (Organovo Holdings, Inc.)
Wednesday, August 9 2017 - 9:00pm
CVS (CVS Health Corporation)
Tuesday, August 8 2017 - 12:30pm
WCG (WellCare Health Plans, Inc.)
Friday, August 4 2017 - 1:00pm
CI (Cigna Corp.)
Friday, August 4 2017 - 12:00pm
TXMD (TherapeuticsMD, Inc.)
Thursday, August 3 2017 - 8:30pm
SYN (Synthetic Biologics Inc.)
Thursday, August 3 2017 - 12:30pm
AET (Aetna Inc.)
Thursday, August 3 2017 - 12:30pm
MOH (Molina Healthcare, Inc.)
Wednesday, August 2 2017 - 9:00pm
TRXC (TransEnterix, Inc.)
Wednesday, August 2 2017 - 8:30pm
HUM (Humana Inc.)
Wednesday, August 2 2017 - 1:00pm
CAH (Cardinal Health, Inc.)
Wednesday, August 2 2017 - 12:30pm
OMI (Owens & Minor Inc.)
Wednesday, August 2 2017 - 12:00pm
TVTY (Tivity Health, Inc.)
Thursday, July 27 2017 - 9:00pm
LH (Laboratory Corp. of America Holdings)
Wednesday, July 26 2017 - 1:00pm
ANTM (Anthem, Inc.)
Wednesday, July 26 2017 - 12:30pm
DGX (Quest Diagnostics Inc.)
Tuesday, July 25 2017 - 12:30pm
CNC (Centene Corp.)
Tuesday, July 25 2017 - 12:30pm
GOOGL (Alphabet Inc.)
Monday, July 24 2017 - 9:00pm
MSFT (Microsoft Corporation)
Thursday, July 20 2017 - 9:30pm

AlphaGraphics you may like